Navigation Links
Actavis Announces 42% Increase to $2.01 in Second Quarter 2013 Non-GAAP Earnings Per Share
Date:7/25/2013

PARSIPPANY, N.J., July 25, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today reported net revenue increased 46.8 percent to $1.99 billion for the second quarter 2013, compared to $1.36 billion in the second quarter 2012. On a non-GAAP basis, diluted earnings per share for the second quarter 2013 were $2.01, compared to $1.42 per diluted share in the second quarter 2012, an increase of 41.5 percent.  On a GAAP basis, the company reported a loss per share for the second quarter 2013 of $4.27, compared to a loss per share of $0.49 in the prior year period. The current quarter GAAP results include an impairment charge following routine annual impairment testing. The accounting related non-cash charge resulted from combining the Company's legacy Arrow business, which was acquired in 2009, with the legacy Actavis Group, which was acquired in 2012. The combined assets were subsequently restructured from one global reporting unit into four new reporting units, resulting in an impairment to goodwill within our European reporting unit. 

For the second quarter 2013, adjusted EBITDA was $474.5 million, compared to $333.0 million for the second quarter 2012.
Cash and marketable securities were $234.9 million as of June 30, 2013.

"Actavis delivered another exceptional quarter of double-digit sales and earnings growth powered by strong generics launches in global markets by Actavis Pharma, continued strong sales of core specialty Brand products and consistent execution by our Global Operations team," said Paul Bisaro, President and CEO of Actavis. 

"In the U.S., we began marketing an authorized generic version of Zovirax® ointment 5%, as part of our marketing and distribution agreement with Valeant, and re-launched Vestura ™, our generic version of Yaz®. Outside of the U.S., Actavis Pharma achieved broad multi-country
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
10. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
11. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 Research ... of the "Inhaled Drug Delivery (London, UK - ... This Inhaled Drug Delivery meeting will cover industry ... and much more. The Co-Chairmen are Dr Steven ... , Senior Director, Mylan. Companies participating ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6mlrvg/an_introduction ) ... Introduction to Medical Device Software: Regulations and Requirements ... to their offering. This course ... and requirements that apply to Medical Device Software. ... life examples and state-of- the-art practices identified from ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 ... the addition of Jain PharmaBiotech,s new report ... Technologies, Markets and Companies" to their offering. ... cell biology of the BBB have opened new ... the CNS. Several carrier or transport systems, enzymes, ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... BOWIE, Md., Dec. 15, 2011  MedAssurant, Inc., ... today announced that Healthcare Partners, IPA (HCPIPA), ... associations (IPA) in the Northeast, has selected ... (CARA™)  solutions to proactively identify gaps in ...
... Mass., Dec. 15, 2011  For parents, knowing how to take ... like sweat or drafts affect the accuracy of results can ... Vicks ® Behind ... out of measuring for fever, restoring confidence to parents and ...
Cached Medicine Technology:Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 2Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 3Behind The Ear -- A New Site To Measure for Fever 2Behind The Ear -- A New Site To Measure for Fever 3
(Date:9/3/2015)... ... September 03, 2015 , ... Mum n Me is pleased to announce the ... extra-large size that gives maximum protection from sun exposure, wind, bugs, and germs. The ... deliver non-slip assurance by keeping the cover securely in place. The new car seat ...
(Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have a hard ... categories: those that have a weak appetite or those that have a fast metabolism. In ... weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The first thing ...
(Date:9/3/2015)... MA (PRWEB) , ... September 03, 2015 , ... ... today announced that Bob Anders and Kelley Chapman will be joining the company’s ... , Anders has over 30 years’ experience in healthcare product and ...
(Date:9/2/2015)... , ... September 03, 2015 , ... The Aspen ... services - two retreats geared towards kick-starting and inspiring wellness in the Roaring Fork ... a part of developing a whole mind-body approach to fitness - we are much ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... determine who among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, health care ... care. This year, that process led the magazine to tap the National League ...
Breaking Medicine News(10 mins):Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3
... , THURSDAY, Feb. 2 (HealthDay News) -- A ... People with a need to please others are more ... study suggests. "People pleasers feel more intense pressure to ... person feel more comfortable," study lead author Julie Exline, a ...
... News) -- A new medication that helps prevent strokes ... as atrial fibrillation poses less risk of bleeding in ... rivaroxaban (Xarelto) and warfarin suggests. Anti-clotting medications, ... aspirin, among others. In patients with atrial fibrillation, these ...
... Initial results of a multicenter study coordinated by ... that two investigational urine-based biomarkers are associated with ... and potentially life-threatening among men who take a ... disease. Ultimately, these markers may lead to the ...
... 2 (HealthDay News) -- ,Greater use of certain types of ... why black children,s risk of ischemic stroke dropped significantly between ... stroke-related deaths between black and white children also fell during ... percent more likely to die of ischemic stroke than white ...
... Chevy Chase, MD -- Intermittent exercise with and without ... in type 2 diabetics, however exercise while under hypoxic ... exercise alone, according to a recent study accepted for ... Endocrinology & Metabolism ( JCEM ). ...
... Minn. Mayo Clinic researchers have found that multiple exposures ... with higher rates of attention-deficit/hyperactivity disorder (ADHD) . ... had more than double the incidence of ADHD than children ... a Mayo Clinic pediatric anesthesiologist and investigator on the observational ...
Cached Medicine News:Health News:'People Pleasers' More Prone to Overeating: Study 2Health News:New Anti-Clotting Drug May Cut Brain Bleeding Risk: Study 2Health News:Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting' 2Health News:Efforts to Reduce Stroke in Kids With Sickle Cell Working: Study 2Health News:Intermittent exercise improves blood glucose control for diabetics 2Health News:Young children exposed to anesthesia multiple times show elevated rates of ADHD 2
CRP Liquid Conrtols level 3...
The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
For the quantitative in vitro determination of Ammonia in plasma...
Medicine Products: